kentucky glp-1 nausea legal team Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs GLP-1 use rises

Description

Innovative pharmacological options are required to cope with the global diabesity pandemic

Fasting glucose (12.135.3 mg/dL

Euglycemic diabetic ketoacidosis (EDKA) is a rare but potentially life-threatening condition that presents with metabolic acidosis and ketonemia in the absence of hyperglycemia

However, that is not the reality: even diabetic patients treated with GLP-1 RAs are more likely to stop them than other second-line anti-diabetic medicines.3 That study didnt report why 50% of diabetics on GLP-1 RAs discontinued them, but gastrointestinal (GI) adverse events were a suggested cause.3 Adverse events are just one of a number of reasons that people stop using these drugs, as follows.

This systematic review examines the current literature on glucagonlike peptide1 receptor agonists (GLP1RAs)associated psychiatric manifestations, including depression, suicidality, eating disorders, substance use disorders (SUD) and ...